Predictive factors for disease recurrence in patients with locally advanced renal cell carcinoma treated with curative surgery
- PMID: 33595988
- DOI: 10.1097/JCMA.0000000000000501
Predictive factors for disease recurrence in patients with locally advanced renal cell carcinoma treated with curative surgery
Abstract
Background: Few prognostic factors have been proposed for patients with locally advanced renal cell carcinoma (RCC). This study aimed to investigate the possible predictive factors for disease-free survival (DFS) after curative surgery for RCC stage T3 or higher.
Methods: Patients with locally advanced RCC who underwent cure-intended partial or radical nephrectomy, with or without tumor thrombectomy, at our institution from April 1, 2005 to October 31, 2013 were retrospectively reviewed. Those undergoing cytoreductive nephrectomy were excluded. Preoperative data, including surgical and pathologic characteristics, were assessed for correlation with DFS. Chi-square tests, univariate and multivariate Cox regression analysis, and Kaplan-Meier survival curve analyses were performed to determine potential predictive factors. A p value less than 0.05 was considered statistically significant.
Results: A total of 159 patients were included for analysis. The mean duration of follow-up was 37.9 months, and 119 (74.8%) patients remained disease-free during follow-up. Disease recurrence was found in 40 (25.2%) patients, and pathologic T stage, capsule penetration, Fuhrman grade, thrombocytosis, renal vein thrombosis, and elevated serum alkaline phosphatase, platelet/lymphocyte ratio, and γ-glutamyl transpeptidase levels were significantly associated with disease recurrence on univariate analysis. On multivariate analysis, Fuhrman grade 3 or 4 (HR = 5.70, p = 0.0003, 95% CI = 2.23-14.56) showed significant associations with DFS.
Conclusion: In patients with locally advanced RCC, Fuhrman grade was associated with worse DFS after curative surgery. Urologists should closely monitor patients with high Fuhrman grades.
Copyright © 2021, the Chinese Medical Association.
Conflict of interest statement
Conflicts of interest: The authors declare that they have no conflicts of interest related to the subject matter or materials discussed in this article.
Comment in
-
Was capsule penetration of locally advanced renal cell carcinoma associated with recurrence in patients undergoing curative surgery?J Chin Med Assoc. 2021 Jun 1;84(6):664. doi: 10.1097/JCMA.0000000000000543. J Chin Med Assoc. 2021. PMID: 33901123 No abstract available.
-
Reply to "Was capsule penetration of locally advanced renal cell carcinoma associated with recurrence in patients undergoing curative surgery?".J Chin Med Assoc. 2021 Jun 1;84(6):665. doi: 10.1097/JCMA.0000000000000548. J Chin Med Assoc. 2021. PMID: 34061811 No abstract available.
References
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018; 68:7–30
-
- Rini BI, Campbell SC, Escudier B. Renal cell carcinoma. Lancet. 2009; 373:1119–32
-
- Shinder BM, Rhee K, Farrell D, Farber NJ, Stein MN, Jang TL, et al. Surgical management of advanced and metastatic renal cell carcinoma: a multidisciplinary approach. Front Oncol. 2017; 7:107
-
- Klatte T, Rossi SH, Stewart GD. Prognostic factors and prognostic models for renal cell carcinoma: a literature review. World J Urol. 2018; 36:1943–52
-
- Leibovich BC, Blute ML, Cheville JC, Lohse CM, Frank I, Kwon ED, et al. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer. 2003; 97:1663–71
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
